SUINING, China, Feb 13, 2008 /Xinhua-PRNewswire via COMTEX/ -- China Health Resources Co., Ltd. (CHRI) announced that Jia Minru, famous professor of the Chinese Medicine University and authoritative Chinese physician, joined CHRI recently to be responsible for deep development, high-tech development and systematic research of deep processed products of Chuan DAR GAP.
The joining of Jia Minru will certainly strengthen the research and development force of CHRI. With the technological advantage of CHRI, Jia will take part in realizing the commercial development with more advanced technology and more commercial value for Suining Chuan DAR and its processed products.
Jia has more than 40 years of research experience in medicine and herb resource development. He was the Advisor of the Chinese Medicine Academy, the Dean of Chinese Medicine University, the deputy dean of Chinese Medicine Association, Director of Chinese Medicine and Herb Committee, and a Member of Sichuan New Medicine Assessment Center.
About the Company
China Health Resources Co., Ltd. (CHRI) was incorporated on April 24, 2001. It is one of China's leading industrialized agricultural corporations. CHRI focuses on the production and further processing of Dahurian Angelica Root (DAR), a herb that is widely used in China, and considered to be an important ingredient in Chinese traditional medicine. CHRI's business plan includes distributing DAR and its processed products to exploit a large market in the areas of treatment of pain, swelling and pustule. Good Agricultural Practice (GAP) is a national compulsory criterion for food and drug industries. The goal of GAP is to help agricultural product companies deal with the usual micro-organism harm so as to enhance safety of agricultural products. CHRI has accomplished GAP certification of Chuan DAR, making DAR products and related production technology of the Company part of the industry criteria.
Statements regarding financial matters in this press release other than historical facts are 'forward-looking statements' within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such proclamations about future expectations, including future revenues and earnings and all other forward-looking statements be subject to the safe harbors created thereby. CHRI depends on outside resources to maintain its continuation. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.